GlassScriptPhysician profile
Paul A Klatte
NPI 1124061106
$825.16
in general payments reported to CMS, 2019-2025
21 companies · $105 in 2025
The $105 reported for 2025 was less than what a typical Diagnostic Radiology provider received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29.46 · 2020: $51.13 · 2021: $104 · 2022: $106 · 2023: $140 · 2024: $290 · 2025: $105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $535.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $534.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $162.45 | 2021-2024 | |
| Merck Sharp & Dohme LLC | $146.91 | 2019-2025 | Keytruda, Reblozyl, Welireg |
| Janssen Biotech, INC. | $57.35 | 2022-2025 | Rybrevant |
| Aveo Pharmaceuticals, INC. | $56.39 | 2022-2023 | Fotivda |
| Amgen INC. | $50.08 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $46.38 | 2021-2023 | Lynparza |
| Bayer Healthcare Pharmaceuticals INC. | $35.75 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $34.73 | 2022-2024 | Gilotrif |
| Celgene Corporation | $30.87 | 2020-2021 | |
| G1 Therapeutics, INC. | $24.00 | 2023 | Cosela |
| Genmab U.S., INC. | $20.68 | 2024 | Epkinly |
| Pfizer INC. | $19.35 | 2024 | |
| Incyte Corporation | $18.34 | 2025 | Zynyz, Monjuvi |
| Genentech USA, INC. | $17.97 | 2023 | Alecensa, Tecentriq |
| Eisai INC. | $17.62 | 2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $17.43 | 2024 | Ninlaro |
| Beigene USA, INC. | $15.16 | 2023 | Brukinsa |
| Genzyme Corporation | $14.11 | 2019 | |
| Emd Serono, INC. | $14.04 | 2023 | Bavencio |
| Lilly USA, LLC | $12.93 | 2021 | |
| Ge Healthcare | $12.62 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Klatte listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.